Establishment and characterization of a new human leukemia cell line derived from M4E0.

Abstract:

:A new human leukemia cell line, designated as ME-1, was established from the peripheral blood leukemia cells of a patient with acute myelomonocytic leukemia with eosinophilia (M4E0). This cell line has the characteristic chromosome abnormality of M4E0, inv(16) (p13q22). When cultured in RPMI 1640 medium containing 10% fetal calf serum, ME-1 cells were monoblastoid, but with the addition of cytokines such as interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-4, or medium conditioned by phytohemagglutinin-stimulated human peripheral leukocytes (PHA-LCM), the cells exhibited differentiation to macrophage-like cells. PHA-LCM also promoted eosinophilic-lineage differentiation of this cell line, although IL-5 did not do so. To elucidate the mechanism of proliferation and differentiation of ME-1 cells, we studied the effect of a potent inhibitor of protein kinase C, 1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine (H-7), on colony formation of ME-1 cells. H-7 inhibited colony formation of ME-1 cells by IL-3 or GM-CSF dose dependently, but had little inhibitory effect on colony formation by IL-4. These results indicate that the proliferation and differentiation of ME-1 cells by IL-3 or GM-CSF were related to the activation of protein kinase C, while those by IL-4 involved other regulatory systems. ME-1 cells should be useful for studying the pathogenesis of M4E0 and the mechanisms of proliferation and differentiation of leukemic and normal progenitors by cytokines.

journal_name

Blood

journal_title

Blood

authors

Yanagisawa K,Horiuchi T,Fujita S

subject

Has Abstract

pub_date

1991-07-15 00:00:00

pages

451-7

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

78

pub_type

杂志文章

相关文献

BLOOD文献大全
  • B-cell development in the thymus is limited by inhibitory signals from the thymic microenvironment.

    abstract::B-cell precursors are present in the thymus, and the thymic microenvironment is the source of lymphopoietic factors that include interleukin-7 (IL-7). Despite the fact that intrathymic B-cell progenitors are bone marrow-derived cells, the data in this report demonstrate that these progenitors accumulate at an early pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0733

    authors: Hashimoto Y,Montecino-Rodriguez E,Leathers H,Stephan RP,Dorshkind K

    更新日期:2002-11-15 00:00:00

  • EB1, p150Glued, and Clasp1 control endothelial tubulogenesis through microtubule assembly, acetylation, and apical polarization.

    abstract::Vascular tube morphogenesis requires the establishment of endothelial cell (EC) apical-basal polarity in three-dimensional (3D) extracellular matrices. To date, there is little understanding of how EC polarity is controlled during these highly dynamic and rapid morphogenic events. We show that the microtubule tip comp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-11-470179

    authors: Kim DJ,Martinez-Lemus LA,Davis GE

    更新日期:2013-04-25 00:00:00

  • A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

    abstract::Although bispecific antibodies directed against malignant lymphoma have been shown to be effective in vitro and in vivo, extended clinical trials so far have been hampered by the fact that conventional approaches to produce these antibodies suffer from low yields, ill-defined byproducts, or laborious purification proc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Löffler A,Kufer P,Lutterbüse R,Zettl F,Daniel PT,Schwenkenbecher JM,Riethmüller G,Dörken B,Bargou RC

    更新日期:2000-03-15 00:00:00

  • Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.

    abstract::Mutations in the kinase domain (KD) of BCR-ABL are the most prevalent mechanism of acquired imatinib resistance in patients with chronic myeloid leukemia (CML). Here we examine predisposing factors underlying acquisition of KD mutations, evidence for acquisition of mutations before and during therapy, and whether the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-066936

    authors: O'Hare T,Eide CA,Deininger MW

    更新日期:2007-10-01 00:00:00

  • High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity.

    abstract::Human invariant natural killer T (iNKT) cells are a rare innate-like lymphocyte population that recognizes glycolipids presented on CD1d. Studies in mice have shown that these cells are heterogeneous and are capable of enacting diverse functions, and the composition of iNKT cell subsets can alter disease outcomes. In ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001903

    authors: Erkers T,Xie BJ,Kenyon LJ,Smith B,Rieck M,Jensen KP,Ji X,Basina M,Strober S,Negrin RS,Maecker HT,Meyer EH

    更新日期:2020-03-12 00:00:00

  • Transcriptional regulation and chromatin structure of the human CD34 gene promoter region.

    abstract::The human CD34 surface antigen is selectively expressed on stem/progenitor cells within the hematopoietic system. Because CD34 expression is tightly linked to the immature status of hematopoietic cells, with expression being rapidly lost as hematopoietic cells mature and differentiate, an examination of its regulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: He XY,Cockerill PN,Cen D,Davis BR

    更新日期:1994-04-01 00:00:00

  • Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient.

    abstract::A hamster antimouse CD3 monoclonal antibody (MoAb) opened the way to experimental studies on the suppression of allograft rejection and cytokine-related morbidity after treatment with antibodies modulating the CD3/T-cell receptor complex (CD3/TCR). Because earlier attempts to suppress graft-versus-host disease (GVHD) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mysliwietz J,Thierfelder S

    更新日期:1992-11-15 00:00:00

  • Hormonal effects on cell proliferation in a human erythroleukemia cell line (K562).

    abstract::We have investigated the hormonal responsiveness of K562 cells using a serum-substituted in vitro clonogenic assay. Dexamethasone inhibited colony formation by the K562 cells, and the inhibitory effect could be reversed by progesterone (10(-6) M). Fluoxymesterone caused a prominent enhancement of K562 colony growth, w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gauwerky C,Golde DW

    更新日期:1980-11-01 00:00:00

  • Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase.

    abstract::p38 MAP kinase in human platelets is activated by platelet agonists including thrombin, thromboxane A2 (TxA2), ADP, and others. However, both upstream mechanisms of p38 MAP kinase activation, and their downstream sequelae, are presently controversial and essentially unclear. Certain studies report sequential activatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-038158

    authors: Begonja AJ,Geiger J,Rukoyatkina N,Rauchfuss S,Gambaryan S,Walter U

    更新日期:2007-01-15 00:00:00

  • Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation.

    abstract::The number of cells transplanted and their capacity to induce graft-versus-host reactivity (GvHR) are two factors that are suspected to influence the engraftment of allogeneic bone marrow. We have investigated their impact on graft rejection rates in busulfan-treated LEW rats. In a series of experiments, we varied (1)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Uharek L,Gassmann W,Glass B,Steinmann J,Loeffler H,Mueller-Ruchholtz W

    更新日期:1992-03-15 00:00:00

  • The peritoneal micromilieu commits B cells to home to body cavities and the small intestine.

    abstract::The distinct combination of homing receptors such as selectins, chemokine receptors, and integrins directs the migration of lymphocytes throughout the body. Upon activation lymphocytes irreversibly switch their set of homing receptors, now guiding them to entirely different destinations. Here we report that exposure o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-12-064345

    authors: Berberich S,Förster R,Pabst O

    更新日期:2007-06-01 00:00:00

  • Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls.

    abstract::Ruxolitinib is JAK1/JAK2 inhibitor with established clinical benefit in myelofibrosis (MF). We analyzed long-term outcomes of 107 patients with intermediate-2 or high-risk MF receiving ruxolitinib at MD Anderson Cancer Center (MDACC) on phase 1/2 trial. After a median of 32 months of follow-up, 58 patients (54%) were ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2012-02-414631

    authors: Verstovsek S,Kantarjian HM,Estrov Z,Cortes JE,Thomas DA,Kadia T,Pierce S,Jabbour E,Borthakur G,Rumi E,Pungolino E,Morra E,Caramazza D,Cazzola M,Passamonti F

    更新日期:2012-08-09 00:00:00

  • The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression.

    abstract::Reactivation of fetal hemoglobin remains a critical goal in the treatment of patients with sickle cell disease and β-thalassemia. Previously, we discovered that silencing of the fetal γ-globin gene requires the erythroid-specific eIF2α kinase heme-regulated inhibitor (HRI), suggesting that HRI might present a pharmaco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005301

    authors: Huang P,Peslak SA,Lan X,Khandros E,Yano JA,Sharma M,Keller CA,Giardine B,Qin K,Abdulmalik O,Hardison RC,Shi J,Blobel GA

    更新日期:2020-06-11 00:00:00

  • The hypercoagulable state in thalassemia.

    abstract::Thalassemia is a congenital hemolytic disorder caused by a partial or complete deficiency of alpha- or beta-globin chain synthesis. Homozygous carriers of beta-globin gene defects suffer from severe anemia and other serious complications from early childhood. The disease is treated by chronic blood transfusion. Howeve...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood.v99.1.36

    authors: Eldor A,Rachmilewitz EA

    更新日期:2002-01-01 00:00:00

  • Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

    abstract::Diverse human cancers with poor prognosis, including many lymphoid and myeloid malignancies, exhibit high levels of Mcl-1. To explore the impact of Mcl-1 overexpression on the hematopoietic compartment, we have generated vavP-Mcl-1 transgenic mice. Their lymphoid and myeloid cells displayed increased resistance to a v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-281071

    authors: Campbell KJ,Bath ML,Turner ML,Vandenberg CJ,Bouillet P,Metcalf D,Scott CL,Cory S

    更新日期:2010-10-28 00:00:00

  • Platelet-associated complement factor H in healthy persons and patients with atypical HUS.

    abstract::Atypical hemolytic uremic syndrome (aHUS) is associated with complement system dysregulation, and more than 25% of pediatric aHUS cases are linked to mutations in complement factor H (CFH) or CFH autoantibodies. The observation of thrombocytopenia and platelet-rich thrombi in the glomerular microvasculature indicates ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-205096

    authors: Licht C,Pluthero FG,Li L,Christensen H,Habbig S,Hoppe B,Geary DF,Zipfel PF,Kahr WH

    更新日期:2009-11-12 00:00:00

  • Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin.

    abstract::Human embryonic stem cells are a promising tool to study events associated with the earliest ontogenetic stages of hematopoiesis. We describe the generation of erythroid cells from hES (H1) by subsequent processing of cells present at early and late stages of embryoid body (EB) differentiation. Kinetics of hematopoiet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-11-011874

    authors: Chang KH,Nelson AM,Cao H,Wang L,Nakamoto B,Ware CB,Papayannopoulou T

    更新日期:2006-09-01 00:00:00

  • A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration.

    abstract::Toll-like receptors orchestrate rapid local protective innate-immune responses to invading pathogens and optimize leukocyte priming of subsequent adaptive responses. Paradoxically, systemic excess of the TLR2 ligand, bacterial lipoprotein (BLP), suppresses peripheral inflammatory responses. Here, we demonstrate that t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-174698

    authors: McKimmie CS,Moore M,Fraser AR,Jamieson T,Xu D,Burt C,Pitman NI,Nibbs RJ,McInnes IB,Liew FY,Graham GJ

    更新日期:2009-04-30 00:00:00

  • Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations.

    abstract::The anemia of chronic disease (ACD) results from 3 major processes: slightly shortened red cell survival, impaired reticuloendothelial system iron mobilization, and impaired erythropoiesis. Hepcidin is an acute-phase protein with specific iron regulatory properties, which, along with the anemia seen with increased hep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2854

    authors: Dallalio G,Law E,Means RT Jr

    更新日期:2006-04-01 00:00:00

  • Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.

    abstract::Treatment outcome of acute myeloid leukemia (AML) in elderly patients remains unsatisfactory. It has been shown that the infusion of granulocyte colony-stimulating factor-mobilized donor peripheral blood stem cells (G-PBSCs) can enhance graft-versus-leukemia effects and speed hematopoietic recovery. Fifty-eight AML pa...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2010-06-288506

    authors: Guo M,Hu KX,Yu CL,Sun QY,Qiao JH,Wang DH,Liu GX,Sun WJ,Wei L,Sun XD,Huang YJ,Qiao JX,Dong Z,Ai HS

    更新日期:2011-01-20 00:00:00

  • Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias.

    abstract::We have investigated the structure of the Ig heavy (IGH) chain locus in 309 cases of acute leukemia. Seventy-one cases of B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) were analyzed: in six cases deletion of joining (JH) segments in the presence of cytogenetically normal chromosome 14 was observed. Similar...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dyer MJ,Heward JM,Zani VJ,Buccheri V,Catovsky D

    更新日期:1993-08-01 00:00:00

  • Timing of neutrophil tissue repopulation predicts restoration of innate immune protection in a murine bone marrow transplantation model.

    abstract::It has been suggested that neutrophil tissue repopulation following bone marrow transplantation (BMT) serves as an earlier and more relevant marker of susceptibility to infection than circulating neutrophil counts. In a previous study using an oral rinse protocol, we found that oral neutrophil recovery always preceded...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-04-018184

    authors: Cheretakis C,Leung R,Sun CX,Dror Y,Glogauer M

    更新日期:2006-10-15 00:00:00

  • A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.

    abstract::The kidney is involved in 70% of patients with immunoglobulin light-chain (AL) amyloidosis, but little is known on progression or reversibility of renal involvement, and criteria for renal response have never been validated. Newly diagnosed patients from the Pavia (n = 461, testing cohort) and Heidelberg (n = 271, val...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-570010

    authors: Palladini G,Hegenbart U,Milani P,Kimmich C,Foli A,Ho AD,Vidus Rosin M,Albertini R,Moratti R,Merlini G,Schönland S

    更新日期:2014-10-09 00:00:00

  • Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside.

    abstract::We investigated treatment with gemtuzumab ozogamicin (GO) in 51 patients aged 65 years or older with newly diagnosed acute myeloid leukemia (AML), refectory anemia (RA) with excess of blasts in transformation, or RA with excess blasts. GO was given in doses of 9 mg/m(2) of body-surface area on days 1 and 8 or, therape...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood.v99.12.4343

    authors: Estey EH,Thall PF,Giles FJ,Wang XM,Cortes JE,Beran M,Pierce SA,Thomas DA,Kantarjian HM

    更新日期:2002-06-15 00:00:00

  • Endogenous peroxidase in the nuclear envelope and endoplasmic reticulum of human monocytes in vitro: association with arachidonic acid metabolism.

    abstract::The development of peroxidase (PO) reaction in the nuclear envelope (NE) and endoplasmic reticulum (ER) of monocytes differentiating in vitro and its relationship with arachidonic acid metabolism were studied. The PO, as visualized by the diaminobenzidine (DAB) technique, appeared in the NE and ER of the majority of m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Deimann W,Seitz M,Gemsa D,Fahimi HD

    更新日期:1984-08-01 00:00:00

  • Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability.

    abstract::Interleukin-8 (IL-8) belongs to a family of chemoattractant cytokines involved in chemotaxis and activation of neutrophils. As in vivo administration of IL-8 induces granulocytosis and the release of immature white blood cells into the circulation, we assessed a possible mobilizing effect of IL-8 on myeloid progenitor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Laterveer L,Lindley IJ,Hamilton MS,Willemze R,Fibbe WE

    更新日期:1995-04-15 00:00:00

  • B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging.

    abstract::Aging is associated with a decline in B-lymphopoiesis in the bone marrow and accumulation of long-lived B cells in the periphery. These changes decrease the body's ability to mount protective antibody responses. We show here that age-related changes in the B lineage are mediated by the accumulating long-lived B cells....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-307983

    authors: Keren Z,Naor S,Nussbaum S,Golan K,Itkin T,Sasaki Y,Schmidt-Supprian M,Lapidot T,Melamed D

    更新日期:2011-03-17 00:00:00

  • Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.

    abstract::Primary effusion lymphoma (PEL) constitutes a subset of non-Hodgkin lymphoma whose incidence is highly increased in the context of HIV infection. Kaposi sarcoma-associated herpesvirus is the causative agent of PEL. The phosphatidylinositol 3-kinase (PI3K) signaling pathway plays a critical role in cell proliferation a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-251082

    authors: Bhatt AP,Bhende PM,Sin SH,Roy D,Dittmer DP,Damania B

    更新日期:2010-06-03 00:00:00

  • Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.

    abstract::Chromosome maintenance protein 1 (CRM1) is a nuclear export receptor involved in the active transport of tumor suppressors (e.g., p53 and nucleophosmin) whose function is altered in cancer because of increased expression and overactive transport. Blocking CRM1-mediated nuclear export of such proteins is a novel therap...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-423160

    authors: Ranganathan P,Yu X,Na C,Santhanam R,Shacham S,Kauffman M,Walker A,Klisovic R,Blum W,Caligiuri M,Croce CM,Marcucci G,Garzon R

    更新日期:2012-08-30 00:00:00

  • Superficial venous thrombosis: recognizing the risk.

    abstract::In this issue of Blood, Roach and colleagues show that individuals with prior superficial venous thrombosis are at increased risk of developing venous thromboembolism when exposed to acquired clinical risk factors. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2013-11-537019

    authors: Bates SM

    更新日期:2013-12-19 00:00:00